Incretins
Showing 1 - 25 of 252
The Role of Incretins in Bone Remodeling in Humans
Recruiting
- Incretins
- +3 more
- blood sample
-
Angers, FranceCHU Angers
Jul 27, 2022
Obesity, Morbid, Diabetes, Type 2, Intestines Trial (Glucemia following Mixed Meal Test, Enteroscopy - mucosal ketogenic
Not yet recruiting
- Obesity, Morbid
- +3 more
- Glucemia following Mixed Meal Test
- Enteroscopy - mucosal ketogenic activity as well as glucose transport
- (no location specified)
Mar 1, 2023
Type2 Diabetes, Obesity, Morbid Trial in Hvidovre (Oral Glucose Tolerance Test, Hyperglycemic clamp with infusion of saline,
Completed
- Type2 Diabetes
- Obesity, Morbid
- Oral Glucose Tolerance Test
- Hyperglycemic clamp with infusion of saline, GLP-1 or GIP
-
Hvidovre, DenmarkHvidovre University Hospital
Mar 14, 2022
Endothelial Dysfunction, Diabetes, Type 1, Biomarkers Trial in Celje (Semaglutide Pen Injector [Ozempic], Empagliflozin 10 MG)
Completed
- Endothelial Dysfunction
- +9 more
- Semaglutide Pen Injector [Ozempic]
- Empagliflozin 10 MG
-
Celje, SloveniaGeneral Hospital Celje
May 10, 2023
Severe Obesity, Type 2 Diabetes in Obese Trial in São Paulo (Analyze basal expression incretin for immunolabeling and mRNA
Recruiting
- Severe Obesity
- Type 2 Diabetes Mellitus in Obese
- Analyze basal expression incretin for immunolabeling and mRNA expression glucagon-like secretion peptide-1 (GLP-1) and peptide YY (PYY 3-36) incretins by L cells.
-
São Paulo, BrazilHospital das Clinicas da Faculdade de Medicina da USP
Jul 7, 2022
COVID 19, Coronavirus, Diabetes, Type 2 Trial in Be'er Ya'aqov, Petah tikva (Linagliptin 5 MG)
Terminated
- COVID 19
- +14 more
- Linagliptin 5 MG
-
Be'er Ya'aqov, Israel
- +2 more
May 28, 2021
Type 2 Diabetes Trial in Dundee (Gliclazide)
Completed
- Type 2 Diabetes Mellitus
-
Dundee, United KingdomNinewells Hospital and Medical School
Feb 20, 2020
Type 2 Diabetes, NAFLD Trial (Drinking powder supplement)
Not yet recruiting
- Type 2 Diabetes
- NAFLD
- Drinking powder supplement
- (no location specified)
Dec 8, 2022
Glycemic Control After Gastric Bypass Surgery in Type 2 Diabetic
Withdrawn
- Type 2 Diabetes
- Obesity
-
Kalmar, SwedenKalmar County Hospital
Aug 5, 2019
Blood Glucose, High, Metabolic Disease, Overweight and Obesity Trial in Halifax (Food)
Recruiting
- Blood Glucose, High
- +2 more
- Food
-
Halifax, Nova Scotia, CanadaMount Saint Vincent University
May 26, 2022
GLP-1, Gut Microbiota Trial in Mexico City (sucralose, )
Recruiting
- GLP-1
- Gut Microbiota
- sucralose
- placebo
-
Mexico City, MexicoInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
Oct 17, 2023
Type2 Diabetes, Obesity Trial (Pine nut oil)
Completed
- Type2 Diabetes Mellitus
- Obesity
- Pine nut oil
- (no location specified)
Dec 11, 2018
Type 2 Diabetes, Obesity Trial in Turku (Roux-en-Y, GIP-infusion, GLP-1)
Completed
- Type 2 Diabetes
- Obesity
- Roux-en-Y
- +4 more
-
Turku, FinlandTurku univercity hospital, PET center
Oct 12, 2021
Pancreas-kidney Transplantation, Kidney Transplantation Trial in LYON cedex 03 (pancreas kidney transplantation, kidney
Completed
- Pancreas-kidney Transplantation
- Kidney Transplantation
- pancreas kidney transplantation
- kidney transplantation
-
LYON cedex 03, FranceHôpital Edourad Herriot - Pavillon P
Nov 28, 2018
Insulin Resistance, Obesity Trial in Tübingen (single bout of moderate intensity continuous training (MICT), single bout of High
Not yet recruiting
- Insulin Resistance
- Obesity
- single bout of moderate intensity continuous training (MICT)
- +2 more
-
Tübingen, GermanyUniversity Clinic Tübingen, Department of Internal Medicine IV
Sep 13, 2023
Healthy, PreDiabetes, Adult Trial (Blood collection)
Not yet recruiting
- Healthy
- +3 more
- Blood collection
- (no location specified)
Oct 5, 2022
Insulin Secretion Trial in Durham (GIP infusion, GLP-1 infusion, Ex-9 infusion)
Suspended
- Insulin Secretion
- GIP infusion
- +2 more
-
Durham, North CarolinaDuke Center for Living
Sep 12, 2022
Obesity, Overweight and Obesity Trial in United States (LY3305677, Placebo)
Not yet recruiting
- Obesity
- Overweight and Obesity
- LY3305677
- Placebo
-
Mesa, Arizona
- +23 more
Nov 6, 2023
Type1diabetes, Hypoglycemia, Type 1 Diabetes Trial in Hellerup (Infusion of GIP[1-42], GIP[1-30] or )
Recruiting
- Type1diabetes
- +2 more
- Infusion of GIP[1-42], GIP[1-30] or placebo
-
Hellerup, Copenhagen, DenmarkCenter for Clinical Metabolic Research, Gentofte Hospital
Nov 17, 2023
Short-Term Beta-Cell Rest in Adolescents and Young Type 2
Completed
- Obesity
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Type 1 Diabetes, Hypoglycemia, Type1diabetes Trial in Hellerup (Infusion of either NST or at different blood glucose levels)
Recruiting
- Type 1 Diabetes
- +2 more
- Infusion of either NST or placebo at different blood glucose levels
-
Hellerup, DenmarkCenter for Clinical Metabolic Research, Gentofte Hospital
Nov 15, 2023
Impaired Glucose Tolerance Trial in Oslo (Salmon fishmeal, Microcrystalline cellulose)
Completed
- Impaired Glucose Tolerance
- Salmon fishmeal
- Microcrystalline cellulose
-
Oslo, Post Box 1046, Blindern, NorwayUniversity of Oslo
Sep 27, 2021
Obesity, Overweight Trial in Puerto Rico, United States (LY3437943, Placebo)
Active, not recruiting
- Obesity
- Overweight
- LY3437943
- Placebo
-
Scottsdale, Arizona
- +27 more
May 10, 2022
Obesity Trial in Rochester (Normal Diet, High Fat Diet, Low Fat Diet)
Completed
- Obesity
- Normal Diet
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Feb 10, 2022
Type 2 Diabetes, Obesity Trial in Rochester (procedure, behavioral, drug)
Completed
- Type 2 Diabetes Mellitus
- Obesity
- Roux-en-Y Gastric Bypass (RYGB)
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Apr 5, 2022